INDIA-EU FTA unlocks access to $572.3 billion EU pharmaceuticals & medical devices market
Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
Granules India has reported total income of Rs. 1,384.29 crore during the period ended December 31, 2025
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
The company also reported significant progress toward its internally defined Sustainable Development Goals
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
The partnership aligns with the launch of Oracle Health’s next-generation electronic health record
Subscribe To Our Newsletter & Stay Updated